REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTIN

被引：0
|
作者：
Udall, M. [1 ]
Mardekian, J. [1 ]
Harnett, J. [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.360
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A64 / A64
页数：1
相关论文
共 50 条
  • [1] Real-World Evaluation of Health-Care Resource Utilization and Costs in Employees with Fibromyalgia Treated with Pregabalin or Duloxetine
    Harnett, James
    Margolis, Jay
    Cao, Zhun
    Fowler, Robert
    Sanchez, Robert J.
    Mardekian, Jack
    Silverman, Stuart L.
    PAIN PRACTICE, 2011, 11 (03) : 217 - 229
  • [2] Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine
    Burke, James P.
    Sanchez, Robert J.
    Joshi, Ashish V.
    Cappelleri, Joseph C.
    Kulakodlu, Mahesh
    Halpern, Rachel
    PAIN PRACTICE, 2012, 12 (03) : 209 - 218
  • [3] HEALTH CARE RESOURCE UTILIZATION AND COSTS IN A SAMPLE OF REAL-WORLD PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    Grabner, M.
    Higuchi, K.
    Ramey, N.
    Toth, P.
    VALUE IN HEALTH, 2014, 17 (03) : A110 - A110
  • [4] PREGABALIN IS ASSOCIATED WITH LOWER HEALTH CARE COSTS AND LESS ABSENTEEISM THAN GABAPENTIN WHEN ADDED TO THE TREATMENT OF NEUROPATHIC PAIN
    Sicras-Mainar, A.
    Rejas, J.
    Navarro-Artieda, R.
    Planas, A.
    Ruiz, L.
    VALUE IN HEALTH, 2011, 14 (07) : A414 - A414
  • [5] OPIOID USE AND COSTS IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY TREATED WITH PREGABALIN OR STANDARD-OF-CARE
    Joshi, A., V
    Mardekian, J.
    Zlateva, G.
    Harnett, J.
    VALUE IN HEALTH, 2010, 13 (03) : A211 - A211
  • [6] Opioid Utilization and Health-Care Costs among Patients with Diabetic Peripheral Neuropathic Pain Treated with Duloxetine vs. Other Therapies
    Wu, Ning
    Chen, Shih-Yin
    Hallett, Lindsay A.
    Boulanger, Luke
    Fraser, Kimberly A.
    Patel, Chintan K.
    Zhao, Yang
    PAIN PRACTICE, 2011, 11 (01) : 48 - 56
  • [7] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
    Tencer, T.
    Xia, Q.
    Jobson, G.
    Qian, E.
    Dellon, E. S.
    VALUE IN HEALTH, 2022, 25 (07) : S432 - S432
  • [8] REAL-WORLD HEALTH CARE RESOURCE UTILIZATION AND COSTS OF HUNTINGTON'S DISEASE IN ISRAEL
    Ribalov, R.
    Yaari, A.
    Chodick, G.
    Barer, Y.
    VALUE IN HEALTH, 2020, 23 : S627 - S627
  • [9] A REAL-WORLD STUDY TO ESTIMATE THE BURDEN OF ILLNESS FOR PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN (DPNP)
    Wang, R.
    Xuan, D.
    Hu, X.
    Xuan, J.
    Ye, X.
    VALUE IN HEALTH, 2022, 25 (07) : S602 - S603
  • [10] Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis
    Tanenberg, Robert J.
    Clemow, David B.
    Giaconia, Joseph M.
    Risser, Richard C.
    PAIN PRACTICE, 2014, 14 (07) : 640 - 648
12345